eMedicine Specialties > Emergency Medicine > Gastrointestinal

Cholecystitis and Biliary Colic

Author: Rahul Sharma, MD, MBA, Instructor in Medicine, Weill Medical College of Cornell University; Consulting Staff, Department of Emergency Medicine, New York Presbyterian Hospital-Weill Cornell Medical Center
Coauthor(s): Sally Santen, MD, Program Director, Assistant Professor, Department of Emergency Medicine, Vanderbilt University
Contributor Information and Disclosures

Updated: Nov 19, 2007

Introduction

Background

Biliary colic and cholecystitis are in the spectrum of biliary tract disease. This spectrum ranges from asymptomatic gallstones to biliary colic, cholecystitis, choledocholithiasis, and cholangitis. In the United States, autopsies have shown that at least 20% of women and 8% of women older than 40 years have gallstones.

Gallstones are divided into 2 categories: Cholesterol (80%) and pigment (20%) ones temporarily obstruct the cystic duct or pass through into the common bile duct, gallstones become symptomatic, and biliary colic develops. Cholecystitis occurs when this obstruction is prolonged (usually several hours) resulting in inflammation of the gallbladder wall. Choledocholithiasis occurs when the stones become lodged in the common bile duct, resulting in possible cholangitis and ascending infections.

Pathophysiology

Cholecystitis is an inflammation of the gallbladder caused by obstruction of the cystic duct. A gallstone usually causes the obstruction (calculous cholecystitis). The inflammation may be sterile or bacterial. The obstruction may be acalculous or caused by sludge. This obstruction can result in gallbladder distention, gallbladder wall edema, ischemia, and necrosis. Additional inflammatory mediators, specifically prostaglandins, are released resulting in increased gallbladder inflammation.

Bacterial infection is thought to be a consequence, not a cause, of cholecystitis. In the early stages of acute cholecystitis, bile is sterile. Approximately 20-75% of bile cultures are eventually positive with the most common organisms being Escherichia coli, Klebsiella species, Enterococci, and Enterobacter. Common bile duct stones (choledocholithiasis, 10%) are either secondary (from the gallbladder) or primary (formed in bile ducts).

Frequency

United States

Prevalence of cholelithiasis is affected by many factors, including race, ethnicity, gender, age, medical problems, and fertility. Between 10-20% of adults (approximately 20 million people) in the United States have gallstones. Each year, only 1-3% of people with stones develop symptoms of gallstones.

International

People of Hispanic or northern European countries are more likely to have stones.

Mortality/Morbidity

  • Asymptomatic gallstones result in morbidity and mortality when they become symptomatic.
  • Mortality can be as high as 15% in immunocompromised patients.
  • Complicated cholecystitis has 25% mortality (eg, gangrene, empyema of gallbladder). Perforation of gallbladder occurs in 3-15% of patients with cholecystitis and is associated with 60% mortality.

Race

  • Racial or ethnic influences are important in gallbladder disease. Fair people of northern European descent are more likely to have gallstones.
  • African Americans are at decreased risk for gallstones unless they have a hematologic reason for stones (eg, sickle cell anemia).
  • Asians with stones are more likely than other populations to have pigmented stones. In elderly Pima Indians, incidence of gallstones is approximately 75%. Increased incidence of stones may be observed in people of Hispanic ethnicity.

Sex

  • The phrase "fair, female, fat, and fertile" summarizes the major risk factors for development of gallstones. Although gallstones and cholecystitis are more common in women, men with gallstones are more likely to develop cholecystitis than women with gallstones.
  • Whether women who are pregnant or have multiple pregnancies are more likely to develop stones or whether they are simply more symptomatic with stones is unknown.
  • Some oral contraceptives or estrogen replacement therapy may increase the risk of gallstones.

Age

  • Age increases rates of gallstones, cholecystitis, and common bile duct stones. Elderly patients are more likely to go from asymptomatic gallstones to serious complications of gallstones without gallbladder colic.
  • Children are more likely than adults to have acalculous gallstones. If stones exist, they are more likely pigmented stones from hemolytic diseases (eg, sickle cell diseases, spherocytosis, G-6-PD deficiency) or chronic diseases (eg, total parenteral nutrition, burns, trauma).
  • Teenagers have the same etiologies of gallstones as adults, with a higher incidence in girls and during pregnancy.

Clinical

History

  • Typical gallbladder colic is 1-5 hours of constant pain, most commonly in the epigastrium or right upper quadrant. Pain may radiate to the right scapular region or back. Peritoneal irritation by direct contact with the gallbladder localizes the pain to the right upper quadrant. Pain is severe, dull or boring, and constant (not colicky). Patients tend to move around to seek relief from the pain. Onset of pain develops hours after a meal, occurs frequently at night, and awakens the patient from sleep. Associated symptoms include nausea, vomiting, pleuritic pain, and fever.
  • Up to 70% of patients with cholecystitis report having experienced similar episodes in the past that spontaneously resolved. Persistence of biliary obstruction leads to cholecystitis and persistent right upper quadrant pain. Character of pain is similar to gallbladder colic except that it is prolonged and lasts hours (usually >6 h) or days. Nausea, vomiting, and low-grade fever are associated more commonly with cholecystitis
  • Indigestion, belching, bloating, and fatty food intolerance are thought to be typical symptoms of gallstones; however, these symptoms are just as common in people without gallstones and frequently are not cured by cholecystectomy.
  • Most gallstones (60-80%) are asymptomatic at a given time. Smaller stones are more likely to be symptomatic than larger ones. Almost all patients develop symptoms prior to complications.
  • Symptoms of cholecystitis are steady pain in the right hypochondrium or epigastrium, nausea, vomiting, and fever. Acute attack often is precipitated by a large or fatty meal.

Physical

  • Vital signs parallel the degree of illness. Patients with cholangitis are more likely to have fever, tachycardia, and/or hypotension. Patients with gallbladder colic have relatively normal vital signs. In a retrospective study, only 32% of patients with cholecystitis had fever. Fever may be absent, especially in elderly patients.
  • Patients with cholecystitis are usually more ill appearing than simple biliary colic patients, and they usually lie still on the examination table since any movement may aggravate any peritoneal signs.
  • Abdominal examination in gallbladder colic and cholecystitis is remarkable for epigastric or right upper quadrant tenderness and abdominal guarding. The Murphy sign (an inspiratory pause on palpation of the right upper quadrant) can be found on abdominal examination. Singer et al found that a positive Murphy sign was extremely sensitive (97%) and predictive (PPV, 93%) for cholecystitis.1 However, in elderly patients, this sensitivity may be decreased.
  • When observed, peritoneal signs should be taken seriously. Most uncomplicated cholecystitis does not have peritoneal signs; thus, search for complications (eg, perforation, gangrene) or other sources of pain.
  • Gallbladder gangrene can be a complication in up to 20% of cases of cholecystitis and is usually in diabetics, elderly, or immunocompromised persons.
  • A palpable fullness in the RUQ may be appreciated in 20% of cases.
  • As in all patients with abdominal pain, perform a complete physical examination, including rectal and pelvic examinations in women.
  • In elderly patients and those with diabetes, occult cholecystitis or cholangitis may be the source of fever, sepsis, or mental status changes.
  • Jaundice is unusual in the early stages of acute cholecystitis and may be found in fewer than 20% of patients.
  • A very high bilirubin should prompt the physician to pay special attention to the common bile duct and pancreatic region.

Causes

Risk factors for biliary colic and cholecystitis include pregnancy, elderly population, obesity, certain ethnic groups, and drugs.

Risk factors for acalculous cholecystitis include diabetes, HIV, vascular disease, total parenteral nutrition, prolonged fasting, or being an ICU patient.

More on Cholecystitis and Biliary Colic

Overview: Cholecystitis and Biliary Colic
Differential Diagnoses & Workup: Cholecystitis and Biliary Colic
Treatment & Medication: Cholecystitis and Biliary Colic
Follow-up: Cholecystitis and Biliary Colic
Multimedia: Cholecystitis and Biliary Colic
References

References

  1. Singer AJ, McCracken G, Henry MC, et al. Correlation among clinical, laboratory, and hepatobiliary scanning findings in patients with suspected acute cholecystitis. Ann Emerg Med. Sep 1996;28(3):267-72. [Medline].

  2. Ralls PW, Colletti PM, Lapin SA, Chandrasoma P, Boswell WD Jr, Ngo C. Real-time sonography in suspected acute cholecystitis. Prospective evaluation of primary and secondary signs. Radiology. Jun 1985;155(3):767-71. [Medline].

  3. American College of Emergency Physicians. Emergency ultrasound imaging criteria compendium. Ann Emerg Med. Oct 2006;48(4):487-510. [Medline].

  4. Bennett GL, Balthazar EJ. Ultrasound and CT evaluation of emergent gallbladder pathology. Radiol Clin North Am. Nov 2003;41(6):1203-16. [Medline].

  5. Burrell MI, Zeman RK, Simeone JF, et al. The biliary tract: imaging for the 1990s. AJR Am J Roentgenol. Aug 1991;157(2):223-33. [Medline].

  6. Flasar MH, Cross R, Goldberg E. Acute abdominal pain. Prim Care. Sep 2006;33(3):659-84, vi. [Medline].

  7. Giurgiu DI, Roslyn JJ. Treatment of gallstones in the 1990s. Prim Care. Sep 1996;23(3):497-513. [Medline].

  8. Gruber PJ, Silverman RA, Gottesfeld S, Flaster E. Presence of fever and leukocytosis in acute cholecystitis. Ann Emerg Med. Sep 1996;28(3):273-7. [Medline].

  9. Houdart R, Perniceni T, Darne B, et al. Predicting common bile duct lithiasis: determination and prospective validation of a model predicting low risk. Am J Surg. Jul 1995;170(1):38-43. [Medline].

  10. Janowitz P, Kratzer W, Zemmler T, et al. Gallbladder sludge: spontaneous course and incidence of complications in patients without stones. Hepatology. Aug 1994;20(2):291-4. [Medline].

  11. Kim MK, Strait RT, Sato TT, Hennes HM. A randomized clinical trial of analgesia in children with acute abdominal pain. Acad Emerg Med. Apr 2002;9(4):281-7. [Medline].

  12. McHale PM, LoVecchio F. Narcotic analgesia in the acute abdomen--a review of prospective trials. Eur J Emerg Med. Jun 2001;8(2):131-6. [Medline].

  13. McSherry CK, Ferstenberg H, Calhoun WF, et al. The natural history of diagnosed gallstone disease in symptomatic and asymptomatic patients. Ann Surg. Jul 1985;202(1):59-63. [Medline].

  14. Moscati RM. Cholelithiasis, cholecystitis, and pancreatitis. Emerg Med Clin North Am. Nov 1996;14(4):719-37. [Medline].

  15. Saini S. Imaging of the hepatobiliary tract. N Engl J Med. Jun 26 1997;336(26):1889-94. [Medline].

  16. Shea JA, Berlin JA, Escarce JJ. Revised estimates of diagnostic test sensitivity and specificity in suspected biliary tract disease. Arch Intern Med. Nov 28 1994;154(22):2573-81. [Medline].

  17. Stevens KA, Chi A, Lucas LC, Porter JM, Williams MD. Immediate laparoscopic cholecystectomy for acute cholecystitis: no need to wait. Am J Surg. Dec 2006;192(6):756-61. [Medline].

  18. Strasberg SM, Clavien PA. Overview of therapeutic modalities for the treatment of gallstone diseases. Am J Surg. Apr 1993;165(4):420-6. [Medline].

  19. Swisher SG, Schmit PJ, Hunt KK, et al. Biliary disease during pregnancy. Am J Surg. Dec 1994;168(6):576-9; discussion 580-1. [Medline].

  20. Tait N, Little JM. The treatment of gall stones. BMJ. Jul 8 1995;311(6997):99-105. [Medline].

  21. Talley NJ. Gallstones and upper abdominal discomfort. Innocent bystander or a cause of dyspepsia?. J Clin Gastroenterol. Apr 1995;20(3):182-3. [Medline].

  22. Thomas SH, Borczuk P, Shackelford J. Patient and physician agreement on abdominal pain severity and need for opioid analgesia. Am J Emerg Med. Oct 1999;17(6):586-90. [Medline].

  23. Thomas SH, Silen W. Effect on diagnostic efficiency of analgesia for undifferentiated abdominal pain. Br J Surg. Jan 2003;90(1):5-9. [Medline].

  24. Thomas SH, Silen W, Cheema F. Effects of morphine analgesia on diagnostic accuracy in Emergency Department patients with abdominal pain: a prospective, randomized trial. J Am Coll Surg. Jan 2003;196(1):18-31. [Medline].

  25. Traverso LW. Clinical manifestations and impact of gallstone disease. Am J Surg. Apr 1993;165(4):405-9. [Medline].

  26. Tsimoyiannis EC, Antoniou NC, Tsaboulas C, Papanikolaou N. Cholelithiasis during pregnancy and lactation. Prospective study. Eur J Surg. Nov 1994;160(11):627-31. [Medline].

  27. Yusoff IF, Barkun JS, Barkun AN. Diagnosis and management of cholecystitis and cholangitis. Gastroenterol Clin North Am. Dec 2003;32(4):1145-68. [Medline].

  28. Zeman RK, Garra BS. Gallbladder imaging. The state of the art. Gastroenterol Clin North Am. Mar 1991;20(1):127-56. [Medline].

Further Reading

Contributor Information and Disclosures

Author

Rahul Sharma, MD, MBA, Instructor in Medicine, Weill Medical College of Cornell University; Consulting Staff, Department of Emergency Medicine, New York Presbyterian Hospital-Weill Cornell Medical Center
Rahul Sharma, MD, MBA is a member of the following medical societies: American College of Emergency Physicians
Disclosure: Nothing to disclose.

Coauthor(s)

Sally Santen, MD, Program Director, Assistant Professor, Department of Emergency Medicine, Vanderbilt University
Sally Santen, MD is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Medical Editor

Samuel M Keim, MD, Associate Professor, Department of Emergency Medicine, University of Arizona College of Medicine
Samuel M Keim, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Public Health Association, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Eugene Hardin, FAAEM, FACEP, Former Chair and Associate Professor, Department of Emergency Medicine, Charles R Drew University of Medicine and Science; Former Chair, Department of Emergency Medicine, Martin Luther King, Jr/Drew Medical Center
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Barry E Brenner, MD, PhD, FACEP, Program Director, Department of Emergency Medicine, University Hospitals, Case Medical Center
Barry E Brenner, MD, PhD, FACEP is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Chest Physicians, American College of Emergency Physicians, American College of Physicians, American Heart Association, American Thoracic Society, Arkansas Medical Society, New York Academy of Medicine, New York Academy of Sciences, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.